Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Diagnostic Hybrids Viral ID Test

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Diagnostic Hybrids' respiratory viral identification kit for use in the US, the company said Tuesday.

Diagnostic Hybrids, which is based in Athens, Ohio, said that the FDA has cleared its D3 Fastpoint L-DFA RSV/MPV Identification kit.

The kit allows for the identification of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in less than 25 minutes.

The kit uses fluorescent labeling technologies and an L-DFA technology that enables simultaneous identification of two respiratory viruses in a single slide.

RSV is the leading cause of infectious viral disease in infants and children under one year old, and hMPV causes diseases in all age groups, and it particularly strikes children and elderly adults, the company said.

Earlier this week, diagnostic firm Quidel said that it had agreed to acquire Diagnostic Hybrids for $130 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.